(firstQuint)Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer.

 In this trial, all the patients will have weekly paclitaxel and cisplatin as neoadjuvant chemotherapy for 4 cycles.

 Patients with Her2 positive tumor will also receive the trastuzumab.

.

 Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer@highlight

The investigators hypotheses that paclitaxel combined with cisplatin in a weekly-based regimen as neoadjuvant chemotherapy is effective and tolerable for locally advanced breast cancer.

